Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Shop Apotheke Europe N.V.    SAE   NL0012044747

SHOP APOTHEKE EUROPE N.V.

(SAE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Shop Apotheke Europe N : continues to grow dynamically; 2019 revenues increase to over EUR 700 million.

share with twitter share with LinkedIn share with facebook
share via e-mail
01/21/2020 | 01:24am EST
SHOP APOTHEKE EUROPE continues to grow dynamically; 2019 revenues increase to over EUR 700 million.

Venlo/Cologne, 21 January 2020. Based on preliminary and unaudited results, SHOP APOTHEKE EUROPE N.V. has clearly met its forecast for the just-ended fiscal year (balance sheet date: 31 December). The online pharmacy again grew dynamically, at a rate of c. 30%, during the 2019 financial year. Preliminary calculations show revenues of around EUR 701 million (2018: EUR 539.7 million) for the 2019 fiscal year with the adjusted EBITDA margin in the projected range of -2.0% to -2.3%. During the fourth quarter 2019, the online pharmacy increased its consolidated revenues to c. EUR 192 million after 151 during the same period a year earlier.

The dynamic revenue growth is due to the rise in the number of active customers in Europa from 3.5 million at the end of 2018 to around 4.7 million at the end of 2019. That means the increase in revenues is almost entirely the result of organic growth (28%).

The sale of prescription drugs (Rx) also increased by about 11% year-on-year. 'We just had a new record of receiving over 7,000 prescriptions on a single day', says SHOP APOTHEKE EUROPE CEO Stefan Feltens. 'We are expecting another substantial increase in our prescription drugs business following the nationwide launch of electronic prescriptions in Germany, which we expect to happen in 2021. Customers will then be able to benefit from all the advantages of online buying.'

SHOP APOTHEKE EUROPE will publish its detailed 2019 financial results in its consolidated financial statement for the 2019 fiscal year on 17 March 2020.


ABOUT SHOP APOTHEKE EUROPE.

SHOP APOTHEKE EUROPE is one of the leading and the fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the OTC, beauty and personal care products as well as prescription drugs segments is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018.

SHOP APOTHEKE EUROPE already operates online pharmacies in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 4.7 million active customers fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services.

SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and is part of the SDAX index since 24 September 2018.

In addition to being traded on the Frankfurt stock exchange, since June 25, 2019, SHOP APOTHEKE EUROPE's convertible bonds (ISIN: DE000A19Y072), are also tradeable on the Dutch Euronext stock exchange, which operates the stock exchanges in Paris, Amsterdam, Brussels and Lisbon.

Disclaimer

Shop Apotheke Europe NV published this content on 21 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 January 2020 06:23:02 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SHOP APOTHEKE EUROPE N.V.
01/21SHOP APOTHEKE EUROPE N : continues to grow dynamically; 2019 revenues increase t..
PU
01/21SHOP APOTHEKE EUROPE N : continues to grow dynamically; 2019 revenues increase t..
EQ
01/08SHOP APOTHEKE EUROPE N : Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE
BU
01/08SHOP APOTHEKE EUROPE N : Jasper Eenhorst named new CFO of SHOP APOTHEKE EUROPE.
EQ
2019SHOP APOTHEKE EUROPE N : increases Group revenues by more than 30% to EUR 509 mi..
EQ
2019SHOP APOTHEKE EUROPE N.V. : Notification and public disclosure of transactions b..
EQ
2019SHOP APOTHEKE EUROPE : Group revenues rise significantly by +31% to around EUR 5..
PU
2019SHOP APOTHEKE EUROPE : Group revenues rise significantly by +31% to around EUR 5..
EQ
2019SHOP APOTHEKE EUROPE N : Triple winner at the 2019-2020 webshop awards.
PU
2019SHOP APOTHEKE EUROPE N.V. : Notification and public disclosure of transactions b..
EQ
More news
Financials (EUR)
Sales 2019 701 M
EBIT 2019 -30,6 M
Net income 2019 -34,1 M
Debt 2019 49,6 M
Yield 2019 -
P/E ratio 2019 -17,9x
P/E ratio 2020 -26,3x
EV / Sales2019 0,96x
EV / Sales2020 0,81x
Capitalization 626 M
Chart SHOP APOTHEKE EUROPE N.V.
Duration : Period :
Shop Apotheke Europe N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHOP APOTHEKE EUROPE N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 49,29  €
Last Close Price 46,50  €
Spread / Highest target 18,3%
Spread / Average Target 5,99%
Spread / Lowest Target -14,0%
EPS Revisions
Managers
NameTitle
Stefan Feltens Chief Executive Officer
Jan Pyttel Chairman-Supervisory Board
Theresa Holler Chief Operating Officer
Ulrich Wandel Chief Financial Officer
Marc Fischer Chief Technical Officer
Sector and Competitors